XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands, shares in Millions
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 290,601 $ 302,028
Restricted cash 10,000 10,000
Accounts receivable, net of allowance for credit losses of $64 and $49 as of March 31, 2024 and December 31, 2023, respectively 5,096 5,942
Prepaid expenses and other current assets 5,915 6,721
Total current assets 311,612 324,691
Property and equipment, net 14,821 14,549
Marketable securities, non-current 447 1,125
Non-marketable equity securities 52,768 52,768
Other non-current assets 2,703 2,693
Total assets 382,351 395,826
Current liabilities:    
Accounts payable 11,371 1,712
Operating lease liabilities, current 1,257 1,364
Other current liabilities 48,854 46,782
Total current liabilities 61,482 49,858
Operating lease liabilities, non-current 10,250 10,573
Common stock warrant liabilities, non-current 2 11
Long-term debt, net of current portion 124,345 123,935
Other non-current liabilities 716 960
Total liabilities 196,795 185,337
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock $0.0001 par value; $10.0 million shares authorized — 0 issued and outstanding as of March 31, 2024 and December 31, 2023 0 0
Common stock $0.0001 par value; 31.3 million shares authorized; Class A common stock – 25.0 million shares authorized; 18.1 million and 18.1 million shares issued; 14.6 million and 15.8 million outstanding as of March 31, 2024 and December 31, 2023, respectively; Class B common stock – 6.3 million shares authorized; 3.4 million shares issued and outstanding as of March 31, 2024 and December 31, 2023 1 1
Treasury stock at cost, 3.5 million and 2.3 million as of March 31, 2024 and December 31, 2023, respectively (19,956) (13,000)
Additional paid-in capital 1,206,703 1,197,963
Accumulated other comprehensive loss (1) (7)
Accumulated deficit (1,001,191) (974,468)
Total stockholders’ equity 185,556 210,489
Total liabilities and stockholders’ equity $ 382,351 $ 395,826
Convertible preferred stock, shares authorized (in shares) 10.0 10.0
Convertible preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 31.3 31.3